This is a preview of subscription content, log in via an institution to check access.
REFERENCE
National Institute for Health and Clinical Excellence.Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer's disease: includes a review of NICE technology appraisal guidance 19. Technology Appraisal Guidance: 1-64, No. 111, Nov 2006. Available from: URL: http://www.nice.org.uk
Rights and permissions
About this article
Cite this article
UK NICE issues therapy guidance for treating AD. Pharmacoecon. Outcomes News 517, 4 (2006). https://doi.org/10.2165/00151234-200605170-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605170-00007